-
Important Australian Study Shows Promise
A study that was recently conducted by researchers at the University of New South Wales in Australia is showing great promise for more accuracy in predicting the survival rate of those suffering from peritoneal mesothelioma. Mesothelioma is fatal form of cancer that can attack various organ linings throughout the body. Peritoneal mesothelioma is one of
-
World Health Organization Report Cites Devastating Statistic
For those who work in health advocacy, and particularly those who focus on asbestos-related diseases, news of loss and waste as a result of exposure to asbestos is nothing new. But a recent report by the World Health Organization (WHO) shocked even those who work with bad news every day. The report, which was published
-
FDA Approves New Cancer Medicine
Afatinib, a new medication that has been raising hopes for those suffering from late-stage lung cancer, has recently been granted approval by the Food and Drug Administration (FDA). This is good news for mesothelioma patients. The drug, which is sold under the brand name Gilotrif, blocks the activity on a gene known as EGFR (epidermal
-
New Mesothelioma Drug Treatment Showing Promise
Plos One, an online publication that offers access to peer-reviewed scientific information, recently released some promising results from a study conducted in Stockholm, Sweden, looking into the effectiveness of a variety of mesothelioma medications. The study looked at a total of six different medications, some of which have long been in use while others have
